Ambroxol Therapy is a pharmacological intervention within the class of mucolytic therapies that specifically employs ambroxol, a bioactive agent enhancing mucociliary clearance and exerting antioxidant and anti-inflammatory effects, to alleviate respiratory conditions characterized by mucus hypersecretion.
164
Publications
6.3K
Citations
863
Authors
323
Institutions
Publications per year
2017–2026
46
Parents
Publications
164
Mucoactive Agents for Airway Mucus Hypersecretory Diseases
Duncan F. Rogers · Respiratory Care · 2007 · 198 citations
Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
Anna Migdalska‐Richards, Liam Daly, Erwan Bézard et al. · Annals of Neurology · 2016 · 196 citations · Full text
1–5 of 164
Authors
863
- AZ
6
h-index
- EPErnesto Pozzi
Istituti di Ricovero e Cura a Carattere Scientifico, Italy
4 publications · 123 citations
4
h-index
- RL
4
h-index
- WA
4
h-index
- CD
4
h-index
1–5 of 863
Institutions
323
Boehringer Ingelheim (Germany)
Ingelheim, Germany
8 h-index
15 publications
268 citations
Fudan University
Shanghai, China
5 h-index
20 publications
878 citations
Shaare Zedek Medical Center
Jerusalem, Israel
5 h-index
15 publications
778 citations
Respiratory Research Institute
Wiesbaden, Germany
4 h-index
5 publications
212 citations
Sant Gadge Baba Amravati University
Amravati, India
4 h-index
7 publications
128 citations
Zhongshan Hospital
Shanghai, China
4 h-index
11 publications
680 citations
Sun Yat-sen University
Guangzhou, China
3 h-index
5 publications
321 citations
University of Pavia
Pavia, Italy
3 h-index
10 publications
274 citations
1–8 of 323
Venues
- PubMed
Repository · 24 publications · 570 citations
15
h-index
- Respiration
10 publications · 239 citations
10
h-index
- Tetrahedron
5 publications · 171 citations
5
h-index
- European Journal of Pharmacology
EJP · 4 publications · 133 citations
4
h-index
- Lung
3 publications · 91 citations
3
h-index
1–5